China Sky One Medical (中国天字一号医药公司) said its subsidiary, Heilongjiang Tianlong Pharmaceutical, received SFDA production approval for four newly developed drugs. These additions bring the company’s totals to eight new products in the last three weeks and 19 so far this year. More details...
Stock Symbol: (NSDQ: CSKI)
Sorry... this feature or article is only available to subscribers.